Skip to main content
Clinical Trials/NCT05811598
NCT05811598
Recruiting
Not Applicable

Random、Control and Open Study of Real Word Study on Myopia Control With Repeated Red Light Therapy for Ages of 3~6 Years Old

Beijing Airdoc Technology Co., Ltd.1 site in 1 country60 target enrollmentMarch 21, 2023
ConditionsMyopiaAmblyopia

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Myopia
Sponsor
Beijing Airdoc Technology Co., Ltd.
Enrollment
60
Locations
1
Primary Endpoint
Mean changes of axial length vaules by millimeter at follow-up from baseline.
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

Repeated Red Light Therapy had been used as an amblyopia therapy for children as well as the myopia control in primary schools. However, ultra low lever of red light therapy with irradiance of 0.37mW and 0.60mW effectiveness and safety for 3~ 6 year-old myopia treatment or slow myopia progression are seldom reported.

Detailed Description

Repeated Red Light Therapy had been used as an amblyopia therapy for children as well as the myopia control in primary schools. However, ultra low lever of red light therapy with irradiance of 0.37mW and 0.60mW effectiveness and safety for 3\~ 6 year-old myopia treatment or slow myopia progression are seldom reported. Here we design this control and random prospective study to find the two types light with different irridance to two ages (3\~4 years old and 5\~6 years old) respectively. Wether the dose and effectiveness exit or not for 3\~6- year- old myopia control.

Registry
clinicaltrials.gov
Start Date
March 21, 2023
End Date
December 30, 2024
Last Updated
3 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • 3\~6 years old;
  • Myopia Spherical Equivalence Refraction \<=-0.50D;
  • Written Informed Consent;

Exclusion Criteria

  • Cannot approval with written informed consent;
  • Photophobia or allergy to red light;
  • With other severe conditions the principle investigators refused to enroll this study

Outcomes

Primary Outcomes

Mean changes of axial length vaules by millimeter at follow-up from baseline.

Time Frame: at 3-month and at 6-month

Ocular axial length measured by IOLmaster500 or Lenstar will be measured and recorded at follow-ups and at baseline. The changes values of axial length of both groups will be compared as the main outcome to compare the effectiveness of repeated red light thearpy.

Secondary Outcomes

  • Numbers of children without myopic refraction changes by spherical equivalence values from refraction at follow-up from baseline(D)(at 3-month and at 6-month)
  • Number of Participants with unsafety issues during the study(at 6-month)

Study Sites (1)

Loading locations...

Similar Trials